Navigation Links
Panacea To Market Measles Vaccine In India

Homegrown pharma major Panacea Biotec today said it is working on four vaccines, including those for treating anthrax and Japanese encephalitis. //

"We are currently working on four vaccines for anthrax, dengue, Japanese encephalitis and hepatitis-A. Phase I and II trials for anthrax vaccine have been completed, which is ready for regulatory approvals," Panacea Biotec Joint Managing Director Rajesh Jain told reporters here today.

The company would also set up its fifth R&D centre, with a strength of 100 scientists, in Navi Mumbai, he said adding, the centre would be operational by next year.

Panacea today entered into a manufacturing and marketing agreement with Indonesian state-run drug company, PT Bio Farma, to supply their measles vaccine in India as well as other global markets.

As part of the agreement, the company would procure bulk vaccines from PT Bio Farma and formulate it into a finished product, which would be sold in India and other defined global markets.

"There is a shortage of measles vaccine in the Indian market with only one company manufacturing such formulations. Panacea plans to fill this demand supply gap with this new deal," Jain said.

The medicine is expected to be ready by end of 2007 and would be available in the market by 2008, he said.

Apart from India, the company would also market the vaccine to UNICEF, African countries, Latin America, Asian region and countries in the middle east, Jain added.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Panacea Biotech To Market Anthrax Vaccine
2. Panacea Biotec In-Licenses FMD Vaccine
3. Websites That Offer Panacea for Eating Disorders may Be Dangerous
4. Panacea Biotech To Market Anthrax Vaccine
5. Ranbaxy Labs Entry Into Anti-Acne Market
6. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
7. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
8. Donated Mothers Milk To Hit The Market
9. New Four- in- one Vaccine For DTP & Hepatitis To Hit The Indian Market
10. Record Growth Of Soya-Based Dairy Alternatives Over The Past Year In European Markets
11. Junk Food Marketing to be banned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... ... 08, 2016 , ... According to research by the National ... technicians to be certified or obtain continuing education. To increase patient awareness of ... Your Mouth?” campaign to inform dentists and patients about the possible lack of ...
(Date:2/7/2016)... ... February 07, 2016 , ... HealthSmart Holdings, Inc. announced today ... the tools and information to lower the costs, and increase the impact of ... providing employee healthcare benefits by as much as 22%:, + Price and ...
(Date:2/6/2016)... ... ... US Sports Camps is proud to sponsor the Bay Area Disc Association's ... leaders, ultimate organizations, and coaches from around the US. The theme for this year’s ... of Youth and Education, describes this year YUCC as “an important conversation we must ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... eating disorder treatment helps to reduce the frequency and level of relapse. ... Phase: Re-Establishing Healthy Identity and Purpose,” will explore the critical tasks of the ...
(Date:2/5/2016)... ... 2016 , ... VeloReality President and co-founder Gary ... VR Indoor Trainer with multi-rider capability to an enthusiastic audience at the company's ... the weight of the unit, they also enhance the rider's experience with a ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016 Vestagen Technical Textiles, Inc., a medical ... healthcare and other demanding applications, today announced it has ... replaces Dale Pfost , PhD, who was serving ... also joining Vestagen,s Board of Directors. ® ... barrier technologies that combines fluid repellent, antimicrobial and breathability ...
(Date:2/8/2016)... Ill. , Feb. 8, 2016  Astellas Pharma Inc. ... announced the promotion of James Robinson as president, ... company,s operations in North and South America ... Astellas Pharma US, representing the commercial organization in ... in 2013. Masao Yoshida , who is ...
(Date:2/8/2016)... , Feb. 8, 2016  CTI BioPharma Corp. ... Company received written communication from the U.S. Food and ... FDA has placed a partial clinical hold on the ... Drug ("IND") application for pacritinib. This clinical hold impacts ... the IND and will also affect planned clinical trials. ...
Breaking Medicine Technology: